Literature DB >> 1952637

Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.

R S Ruiz1, O A Saatci.   

Abstract

The retinopathy caused by antimalarials is well known. The differences between antimalarials and daily and cumulative doses are important factors in predicting the development of retinopathy. None of the commonly used tests alone are satisfactory for detecting early retinal changes. We recommend baseline color fundus photographs and automated central visual fields to follow these patients every nine to 12 months. Between these examinations, Amsler grid testing is adequate for screening for early defects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952637

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  4 in total

1.  Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy.

Authors:  A Almony; S Garg; R K Peters; R Mamet; J Tsong; B Shibuya; R Kitridou; A A Sadun
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

2.  Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.

Authors:  Kimberly E Stepien; Dennis P Han; Jonathan Schell; Pooja Godara; Jungtae Rha; Joseph Carroll
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

3.  Hydroxychloroquine retinopathy screening.

Authors:  A E Semmer; M S Lee; A R Harrison; T W Olsen
Journal:  Br J Ophthalmol       Date:  2008-10-01       Impact factor: 4.638

4.  Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.

Authors:  Scott C So; Thomas R Hedges; Joel S Schuman; Maria Luz Amaro Quireza
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.